NOVOCURE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.88 USD | -6.48% |
|
-13.17% | +13.06% |
| 09-03 | NovoCure CEO Asaf Danziger to Retire, CFO Ashley Cordova Named Successor | MT |
| 09-03 | Novocure Announces CEO Changes, Effective January 1, 2025 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NOVOCURE LIMITED | Medical Equipment | -6.48% | -13.17% | +13.06% | -18.41% | -80.29% | 1.83B |  |  |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- NVCR Stock
- Charts NovoCure Limited
- Comparison Chart
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition